SCHEMBL7130241

SCHEMBL7130241

NC(=O)c1ccc(S(=O)(=O)NC(CCc2ccccc2)C(=O)NC2CCCCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 2/20 0.54
HPN P05981 2/20 0.54
MMP2 P08253 6/20 0.53
MMP9 P14780 4/20 0.53
MMP8 P22894 1/20 0.53
MMP12 P39900 1/20 0.53
MMP14 P50281 1/20 0.53
ALDH1A1 P00352 4/20 0.50
MCL1 Q07820 1/20 0.50
PPARG P37231 1/20 0.47
HTT P42858 2/20 0.47
TSHR P16473 2/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7118677 0.82 MMP2 (0.49) PLAUHPNMMP2MMP9MMP8
SCHEMBL7116706 0.81 PLAU (0.59) PLAUHPNMMP2MMP9MMP8
SCHEMBL7116600 0.81 F2 (0.59) PLAUHPNMMP2MMP9MMP8
SCHEMBL7127019 0.79 PLAU (0.60) PLAUHPNMMP2MMP9ALDH1A1
SCHEMBL21012486 0.72 EPHX1 (0.58) MMP2ALDH1A1HTTTSHRL3MBTL1
SCHEMBL8719658 0.71 F2 (0.46) HPNMMP2MMP9MMP8MMP12
SCHEMBL30882700 0.71 TAAR1 (0.52) MMP2ALDH1A1HTTTSHREPHX2
SCHEMBL13271642 0.70 EPHX1 (0.56) MMP2ALDH1A1HTTTSHREPHX2
SCHEMBL7130244 0.70 HTT (0.41) PLAUHPNALDH1A1MCL1PPARG
SCHEMBL8707457 0.70 ALDH1A1 (0.63) MMP2MMP9MMP8MMP12MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO PLAU 1115/4885HPN 247/4885MMP2 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.